EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 68 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,398,023 | -27.8% | 300,128 | -21.4% | 1.61% | -28.6% |
| Q2 2023 | $3,323,400 | +272.6% | 382,000 | +25.9% | 2.25% | +242.8% |
| Q1 2023 | $891,984 | -16.0% | 303,396 | 0.0% | 0.66% | +0.6% |
| Q4 2022 | $1,061,886 | -55.8% | 303,396 | 0.0% | 0.65% | -36.8% |
| Q3 2022 | $2,400,000 | +0.5% | 303,396 | 0.0% | 1.03% | -22.3% |
| Q2 2022 | $2,388,000 | -36.2% | 303,396 | -1.5% | 1.33% | -23.9% |
| Q1 2022 | $3,742,000 | +25.8% | 307,944 | +26.7% | 1.75% | +39.8% |
| Q4 2021 | $2,975,000 | -22.8% | 243,072 | -34.3% | 1.25% | -8.1% |
| Q3 2021 | $3,854,000 | +15.9% | 369,863 | 0.0% | 1.36% | +2.3% |
| Q2 2021 | $3,325,000 | -14.1% | 369,863 | -3.0% | 1.33% | -4.8% |
| Q1 2021 | $3,872,000 | – | 381,145 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |